ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

Research Pharmacy

Completed
Institution
SLOAN-KETTERING INST CAN RESEARCH, NY
Principal investigator
Scott Freeswick
Funding
$614K
Duration
1997–2026
Open portfolio

Moonbase score

Still being scored

Abstract

ABSTRACT The Research Pharmacy (RP) Core provides a full service facility that prepares agents developed by MSK researchers to be used as investigational drugs in preclinical or clinical studies. The Core comprises three principal groups: the Pharmaceutical Product Facility (PPF) for drug formulation/stability and preparation; the Clinical Grade Production (CGP) Facility for bulk product manufacturing, purification, and vialing; and the Pharmacy Investigational Drug Service (PIDS), which provides a service to develop, procure, prepare, and validate the preparation, packaging, and distribution of investigational drugs for clinical use. The Core services include, but are not limited to, formulation, analysis, and evaluation of drug release rates; prediction of interactions; and determinations of compatibility and physical stability of medications. Owing to the infrastructure of the Core, MSK has been able to bring into early phase clinical trials multiple distinct types of pharmacologic agents, including traditional small molecules, radiopharmaceuticals, and vaccines.

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEP30Cancer Centers Study Section (A)[NCI-A]pharmacyinvestigationalfacilityformulationservicedrug releasedeterminationsmsk

Questions for SLOAN-KETTERING INST CAN RESEARCH

Answered by the team behind this research.

Same institution, same topic, scored first.